EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease: Interdisciplinary Considerations and Management

Erin Walsh iD, Livia Guadagnoli iD, Julie M Barkmeier-Kraemer, Gregory Dion, Jackie Gartner-Schmidt, Mami Kaneko, Jerome R Lechien iD, John E Pandolfino, Anne Vertigan iD, C Prakash Gyawali, Rena Yadlapati, Justin Wu und 1 weitere

Neurogastroenterology & Motility · 2026-06 · 38 (6)

DOI: 10.1111/nmo.70383 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 22.06.2026. Verfasst von Erin Walsh und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, University of California San Diego Health, La Jolla, California, USA. Hauptthemen laut MEDLINE: Laryngopharyngeal Reflux, Disease Management. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The San Diego Consensus for Laryngopharyngeal Symptoms (LPS) and Laryngopharyngeal Reflux Disease (LRPD) describes a broad‐based multidisciplinary management paradigm that focuses on mechanisms underlying symptoms to improve treatment outcomes.

Purpose

This review expands on the San Diego Consensus framework to discuss multidisciplinary management of LPS and LPRD. LPS manifest as persistent or disproportionate symptoms despite minimal or inconsistent evidence of reflux exposure. Emerging evidence suggests that hyperresponsiveness, hypervigilance, and symptom‐specific anxiety are more strongly associated with LPS than objective reflux metrics and may contribute to symptom persistence through heightened attention to perceived irritation and protective behavioral responses. Repeated peripheral sensory input may further contribute to central sensitization and lower perceptive thresholds. While these behavioral and neurophysiological processes may be partially improved by reducing reflux exposure, behavioral therapies that address the multidimensional nature of LPS may provide additional benefit. Laryngeal Recalibration Therapy addresses LPS by retraining maladaptive laryngeal behaviors, enhancing vagal tone via heart rate variability biofeedback, and cognitive reframing to reduce symptom amplification. Meta‐therapy, a clinical dialogue approach used in speech‐language pathology to facilitate behavioral change, alongside psychological interventions such as mindfulness meditation, cognitive‐behavioral therapy, and gut‐directed hypnotherapy, may further target cognitive–affective processes that shape perception. Behavioral interventions can be combined with neuromodulators, particularly delta ligands such as gabapentin in patients with chronic cough, and tricyclic antidepressants or selective serotonin reuptake inhibitors in select cases. Effective management relies on multidisciplinary collaboration, integration of reflux‐directed and behavioral therapies, and patient‐centered education that supports adaptive symptom interpretation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laryngopharyngeal RefluxDisease ManagementHumans

Stichwörter der Autor:innen

hypervigilancelaryngeal hyperresponsivenesslaryngeal recalibration therapylaryngopharyngeal reflux diseaselaryngopharyngeal symptomssymptom‐specific anxiety

Autor:innen und Institutionen

  • Department of Otolaryngology, University of California San Diego Health, La Jolla, California, USA.
  • Kenneth C. Griffin Esophageal Center Northwestern Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Department of Communication Sciences & Disorders, Department of Otolaryngology-Head & Neck Surgery, University of Utah, Salt Lake City, Utah, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati, Cincinnati, Ohio, USA.
  • Department of Speech-Language Pathology, Carlow University, Pittsburgh, Pennsylvania, USA.
  • Department of Molecular Cell Physiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

ORCID-Profile: Erin Walsh, Livia Guadagnoli, Jerome R Lechien, Anne Vertigan

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Walsh, E., Guadagnoli, L., Barkmeier-Kraemer, J. M., Dion, G., Gartner-Schmidt, J., Kaneko, M., Lechien, J. R., Pandolfino, J. E., Vertigan, A., Gyawali, C. P., Yadlapati, R., Wu, J., & San Diego Consensus Working Group (2026). Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease: Interdisciplinary Considerations and Management. Neurogastroenterology & Motility, 38(6). https://doi.org/10.1111/nmo.70383

Vancouver

Walsh E, Guadagnoli L, Barkmeier-Kraemer JM, Dion G, Gartner-Schmidt J, Kaneko M, et al. Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease: Interdisciplinary Considerations and Management. Neurogastroenterology & Motility. 2026;38(6). doi:10.1111/nmo.70383

BibTeX
@article{Walsh2026,
  author = {Walsh, Erin and Guadagnoli, Livia and Barkmeier-Kraemer, Julie M and Dion, Gregory and Gartner-Schmidt, Jackie and Kaneko, Mami and Lechien, Jerome R and Pandolfino, John E and Vertigan, Anne and Gyawali, C Prakash and Yadlapati, Rena and Wu, Justin and San Diego Consensus Working Group, San Diego Consensus Working Group},
  title = {Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease: Interdisciplinary Considerations and Management},
  journal = {Neurogastroenterology & Motility},
  year = {2026},
  volume = {38},
  number = {6},
  doi = {10.1111/nmo.70383}
}
Kostenlos starten →